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Tombusviruses, which are small plus-strand RNAviruses of plants, require the viral-coded p33 replication co-factor for template selection
and recruitment into replication in infected cells. As presented in the accompanying paper [Shapka, N., Stork, J., Nagy, P.D., 2005.
Phosphorylation of the p33 replication protein of Cucumber necrosis tombusvirus adjacent to the RNA binding site affects viral RNA
replication. J. Virol. 343, 65–78.], p33 can be phosphorylated in vitro at serine and threonine residues adjacent to its arginine–proline-rich
RNA binding site. To test the effect of phosphorylation on p33 function, in this paper, we used phosphorylation-mimicking aspartic acid
mutants of Cucumber necrosis virus (CNV) p33 and in-vitro-phosphorylated p33 in gel mobility shift experiments. We found that
phosphorylation inhibited the ability of p33 to bind to the viral RNA. In contrast, the nonphosphorylation-mimicking alanine mutants of p33
bound to viral RNA as efficiently as the nonphosphorylated wild type p33 did. In vitro assays with purified CNV replicase preparations
revealed that phosphorylation-mimicking mutants of p33 did not support the assembly of functional CNV replicase complexes in yeast, a
model host. Based on these results, we propose that the primary function of reversible phosphorylation of p33 is to regulate the RNA binding
capacity of p33, which could affect the assembly of new viral replicase complexes, recruitment of the viral RNA template into replication
and/or release of viral RNA from replication. Thus, phosphorylation of p33 might help in switching the role of the viral RNA from replication
to other processes, such as viral RNA encapsidation and cell-to-cell movement in infected hosts.
D 2005 Elsevier Inc. All rights reserved.Keywords: In vitro replication; Tombusvirus; RNA synthesis; RNA binding; PhosphorylationIntroduction
Posttranslational modification of proteins affects the
functions and stability of many cellular proteins, such as
those involved in the control of gene expression, signal
transduction and cell cycle regulation. The most common
posttranslational modification is reversible phosphorylation/
dephosphorylation, which could serve as a switch between
active and inactive forms of proteins (Hunter and Karin,
1992). For example, an important cellular antiviral defense
system depends on dsRNA-triggered phosphorylation/acti-0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: pdnagy2@uky.edu (P.D. Nagy).vation of PKR, which then leads to phosphorylation of
eIF2alpha and inhibition of translation (Gunnery and
Mathews, 1998). The Tat protein of Human immunodefi-
ciency virus-1 (HIV) is known to inhibit PKR activity by
competing with eIF2 for phosphorylation by the activated
PKR. The interaction between Tat and PKR requires the
RNA binding region of Tat (Brand et al., 1997; Gunnery and
Mathews, 1998). Phosphorylation of serine/threonine resi-
dues is also known to regulate the formation of protein
complexes (Pawson and Scott, 1997), and it can also be
used as a signal to trigger ubiquitination and degradation of
proteins (King et al., 1996). Phosphorylation of viral
proteins is also common. The examples include regulation
of function of the viral movement proteins (MP) in plants
(Karpova et al., 1999; Sokolova et al., 1997; Trutnyeva et005) 79 – 92
Fig. 1. Proposed effect of CNV p33 phosphorylation on its ability to bind
to the viral RNA. (A) The known functional domains in p33 are shown
schematically. (B–C) The positively charged amino acid sequence of the
RPR motif involved in RNA binding and the predicted S/T phosphor-
ylation sites are shown. The possible interactions between positively and
negatively charged moieties are indicated with dotted lines. The model
predicts that the nonphosphorylated p33 could bind stably to the viral
RNA, whereas the phosphorylated form might not bind to the viral RNA
due to the competition between the negatively charged phosphate groups
and the RNA. Note that the hairpin structure illustrates RII(+)-SL with the
CIC mismatch, which constitutes p33RE (Pogany et al., 2005).
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binds to the viral RNA less efficiently than the non-
phosphorylated form, which might be important in facilita-
ting the release of the bound RNA from the MP:RNA
complex during cell-to-cell movement of viral RNAs (Lee
and Lucas, 2001; Waigmann et al., 2000). Binding of coat
protein to viral RNA is also inhibited by phosphorylation
(Ivanov et al., 2001, 2003; Kann et al., 1999). Protein
phosphorylation can also regulate intracellular distribution
of viral proteins (Kann and Gerlich, 1994). Another role of
phosphorylation/dephosphorylation is to regulate virus
replication. For example, protein:RNA interaction and
replicase assembly of animal negative-strand RNA viruses
are controlled by phosphorylation (Barik and Banerjee,
1992; Gao and Lenard, 1995; Gao et al., 1996; Lenard,
1999; Takacs et al., 1992). Rapid formation of RNA binding
site in the HIV Rev protein is promoted by phosphorylation
of serine residues (Fouts et al., 1997). Similarly, phosphory-
lation of Rex protein of human T-cell leukemia virus
(HTLV) alters the conformation of Rex and its ability to
bind to viral RNA, which serves as a switch between the
latent and productive phases of the HTLV infection cycle
(Narayan et al., 2001; Younis and Green, 2005). Phosphory-
lation of replication proteins of animal and plant viruses has
also been documented, which could regulate interaction
between the replication proteins (Evans et al., 2004;
Hericourt et al., 2000; Kim et al., 2002; Puustinen et al.,
2002; Street et al., 2004). However, the role of phosphory-
lation/dephosphorylation of replication proteins in plus-
strand RNA virus replication is currently poorly understood.
Tombusviruses, such as Tomato bushy stunt virus
(TBSV) and Cucumber necrosis virus (CNV), are popular
model viruses (White and Nagy, 2004). They have a
nonsegmented genomic RNAwith five open reading frames
(ORF), two of which code for essential replication proteins,
termed p33 and p92. The auxiliary p33 is a replication co-
factor that plays a role in template selection (Pogany et al.,
2005) and recruitment into replication (Monkewich et al.,
2005; Panavas et al., 2005) via selectively binding to a
conserved stem-loop element [RII-SL(+), a high-affinity
binding sequence for p33, termed p33 recognition element,
or p33RE; Fig. 1B] present within the p92 ORF. P33 binds
to the viral RNAvia its arginine–proline-rich (RPR) domain
(Fig. 1A), which was shown to be essential for tombusvirus
replication (Panaviene et al., 2003; Rajendran and Nagy,
2003), and it also affects subgenomic RNA synthesis and
RNA recombination (Panaviene and Nagy, 2003). Together,
with the viral RNA, p33 is required for the assembly of the
functional replicase complex (Panaviene et al., 2004, 2005),
which also contains the p92 RNA-dependent RNA polymer-
ase and possibly host factors. In addition to protein:RNA
interactions, the assembly of the replicase might be aided by
interactions between p33 and other p33 and p92 molecules,
which are essential for replication (Rajendran and Nagy,
2004). Altogether, p33 seems to be a multifunctional protein
affecting viral RNA replication (White and Nagy, 2004),RNA recombination (Panaviene and Nagy, 2003) and
possibly other processes (Burgyan et al., 2000).
Recent identification of phosphorylation-based modifi-
cation of p33 (see accompanying paper by Shapka et al.,
2005) opens up the possibility that the activity of the p33
replication protein might be regulated by phosphorylation/
dephosphorylation in CNV-infected plants. In vitro phos-
phorylation studies mapped the sites of phosphorylation in
p33 to serine (S210) and threonine (T211, possibly T205)
residues located adjacent to the RNA binding site (Fig. 1C).
Neutral alanine (A) mutations, which mimic the non-
phosphorylated form of p33, at these sites were found to
affect the synthesis of plus versus minus strands and alter
the ratio between the two subgenomic RNAs. On the
contrary, the phosphorylation-mimicking aspartic acid (D)
mutations that, like phosphorylation, introduced negative
charges at these positions rendered the virus non-infectious
in plant protoplasts. To determine what functions of p33
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we conducted in vitro RNA binding experiments with
recombinant p33 preparations. The obtained data demon-
strate that D mutations in p33 at the phosphorylation sites
reduced the ability of p33 to bind to viral RNA, while A
mutations had lesser effects. We also found that the above D
mutations in p33, but not in p92, inhibited the activity and/
or the assembly of functional replicase complexes in yeast.
Altogether, we propose that phosphorylation of p33
replication protein is involved in regulation of CNV
replication due to affecting the ability of p33 to bind to
the viral RNA.Results
Rationale
Phosphorylation of threonine (T205 and T211) and serine
(S210) residues adjacent to the arginine (R) and proline (P)-
rich RPR motif (R213P214R215R216R217P218) (Fig. 1) is
predicted to affect the ability of p33 to bind to the viral
RNA. This is because phosphorylation makes these residues
negatively charged that could ‘‘neutralize’’ the proximal
positively charged R residues within the RPR motif.
Therefore, the negatively charged phosphorylated residues
could compete with the negatively charged RNA for binding
to the positively charged RPR motif in p33. Overall, we
predict that phosphorylation of p33 might affect two
functions of p33: facilitating (i) binding/release of the viral
RNA to/from the replicase complex during replication; and
(ii) assembly/disassembly of the replicase complex, which
in addition to p92, also contains the viral RNA, p33 and
possible host factors. These models were tested below.
Phosphorylation of p33 adjacent to the RPR motif inhibits
viral RNA binding in vitro
To test the effect of phosphorylation on the ability of
p33 to bind to the viral RNA, first, we utilized
phosphorylation-mimicking mutants of recombinant p33.
The phosphorylation-mimicking mutants carried D for T/S
mutations, which introduced negative charges comparable
to that of phosphorylation (Freye-Minks et al., 2003;
Jabbur et al., 2001; Jia et al., 2004; Waigmann et al.,
2000). On the contrary, nonphosphorylated form of p33
was mimicked by A for T/S mutations, which maintain
neutral charges at the phosphorylation sites. Moreover,
hypo(partial)phosphorylation-mimicking mutants contained
a single D mutation at either T205, S210 or T211 positions.
Importantly, both D and A residues are similar in size to T/
S residues, thus minimizing the sterical/structural effects
caused by these mutations. However, it is important to
note that D mutations only ‘‘mimic’’ phosphorylation, thus
results obtained with D mutants could possibly cause
problems unrelated to phosphorylation.Altogether, we generated nine p33 mutants with A and/or
D mutations at the phosphorylation sites (Figs. 2A–D).
These proteins were expressed in E. coli as fusion proteins
with the maltose-binding protein (MBP) followed by affinity
purification (Fig. 2E) as described (Rajendran and Nagy,
2003; Rajendran et al., 2002). Note that, instead of the full-
length protein, we used a truncated version of p33, which
lacked the mostly hydrophobic N-terminal domain. The N-
terminal domain contains membrane-anchoring sequences,
and it does not contribute to RNA binding in vitro (Pogany et
al., 2005; Rajendran and Nagy, 2003). The purified recombi-
nant p33 was used in a gel electrophoretic mobility-shift
assay (EMSA) (Fig. 2) to test its binding to a 32P-labeled
RNA probe consisting of RII(+)-SL, which includes the high-
affinity binding sequence p33RE (Pogany et al., 2005). The
EMSA experiments demonstrated that alanine mutations (see
A210A211, Fig. 2A), which mimic the nonphosphorylated
form of p33, had no inhibitory effect on RNA binding by p33.
In contrast, the phosphorylation-mimicking D210D211 p33
bound to the RNA probe poorly when compared to the
nonphosphorylated p33 control (Fig. 2B). Thus, the phos-
phorylation-mimicking, but not the nonphosphorylation-
mimicking mutations, inhibited the ability of p33 to bind to
the p33RE-containing viral RNA in vitro.
To test which of the three phosphorylation sites (i.e.,
T205, S210 or T211) have more pronounced effect on RNA
binding, we compared additional p33 mutants carrying
different combinations of A/D mutations at these phospho-
rylation sites. The RNA binding abilities of these recombi-
nant p33 proteins revealed that D mutation at position T211
was especially inhibitory on RNA binding (see mutants D211
and A210D211, Figs. 2B–C). The presence of D residue at
position S210 also had inhibitory effect on RNA binding (see
mutants D210 and D210A211, Figs. 2B–C). Phosphorylation-
mimicking D mutation at position 205 had lesser effect on
RNA binding (compare mutant D205A210A211 with
A205A210A211, Figs. 2D–E). We also tested the RNA
binding activity of triple phosphorylation-mimicking mutant
(i.e., D205D210D211), which showed minimal RNA binding
activity when compared to the nonphosphorylation-mimick-
ing mutant (A205A210A211). Altogether, these data suggest
that each of the phosphorylation sites (T205, S210 or T211)
could be involved in regulation of RNA binding by p33, and
their relative effects are inversed with their distances from
the RPR motif (see Discussion).
To test if the phosphorylation-mimicking mutation could
affect the ability of p33 to bind to plus- and minus-stranded
RNA templates, we used EMSA experiments similar to
those described above except using full-length model
templates representing replication-competent defective
interfering RNA (termed DI-72 RNA). While the wt p33C
bound efficiently to both DI-72(+) and DI-72() RNA, the
binding of D210D211 to both RNAs was less efficient (Fig.
3). Altogether, these data suggest that the overall RNA
binding capacity of p33 is inhibited by the presence of
phosphorylation-mimicking mutations.
Fig. 2. Reduced RNA binding by the phosphorylation-mimicking p33 mutants in vitro. (A–D) EMSA was performed with various purified recombinant p33
carrying nonphosphorylation-, hypophosphorylation- and phosphorylation-mimicking mutations, respectively, at T205, S210 and/or T211 positions. The RNA
probe was 32P-labeled RII(+)-SL, which includes p33RE sequence. The proteins were used in increasing amounts (2-fold increase, up to 200 Ag/ml). The
migration of the unbound and bound RNAs is shown on the right of the gel images. The experiments were performed three times. (E) Coomassie-stained SDS-
PAGE shows that the purified p33 preparations had comparable quantity and quality.
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ylation on the ability of p33 to bind to the viral RNA
included in vitro phosphorylation of recombinant wt p33
with protein kinase C (PKC). We used PKC in this
experiment because PKC has been found to phosphorylate
p33 more efficiently than a plant kinase preparation in
vitro (Shapka et al., 2005 accompanying paper). EMSA
performed with the kinased p33 demonstrated that the
phosphorylated recombinant p33 bound to the viral RNA
probe up to 3-fold less efficiently than the untreated p33could (Fig. 4A). It is likely that PKC treatment had
inhibitory effect on RNA binding capacity of p33 due to
phosphorylation of S210 and T211 because the nonphos-
phorylatable A210A211 mutant of p33 did not show reduced
efficiency of binding in the treated versus untreated
samples (Fig. 4A). Accordingly, PKC has been shown to
phosphorylate only S210 and T211, in p33 in vitro (see the
accompanying paper by Shapka et al., 2005).
Because treatment of p33 with PKC inhibited RNA
binding only at low p33 concentrations (Fig. 4A,
Fig. 3. The nonphosphorylated wt p33 binds both DI-72(+) and ()RNA more efficiently than the phosphorylation-mimicking mutant. EMSAwas performed
with purified recombinant p33 preparations, either wt or D210D211 as described under Fig. 2. The p33 protein was used in increasing amounts (2-fold increase,
up to 200 Ag/ml), whereas the same amounts of 32P-labeled DI-72(+) and DI-72() RNAs were applied. The percentage of bound RNA is shown graphically at
the bottom. The unbound RNA probe in the absence of p33 is taken as 100%.
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p33 in Fig. 4A (lanes 1–3) is due to incomplete phosphor-
ylation of all p33 molecules present in solution. To test more
rigorously if phosphorylated p33 maintains the ability to
bind to the viral RNA probe, we developed a new EMSA
assay in which p33 was 32P-labeled (Fig. 4B), whereas the
viral RNA [RII(+)-SL probe, Fig. 4B, lanes 4–5] was
unlabeled. Visualization of the viral RNA with ethidium
bromide staining and the p33 with Coomassie staining
revealed the presence of p33:RNA complexes (Fig. 4B, leftand middle panels, lanes 4–5) that were not present when the
mutated DC99 RNA, which cannot bind to p33 (Pogany et
al., 2005), was used as a probe (Fig. 4B, lanes 2–3).
Importantly, the p33:RNA complexes were not labeled with
32P (Fig. 4B, right panel, lanes 4–5), suggesting that the
unphosphorylated p33 still present after PKC treatment, but
not the phosphorylated p33 (32P-labeled), was responsible
for the observed shift in RNA:protein mobility. Based on
these experiments, we conclude that the phosphorylated p33
is unlikely to bind to the viral RNA in vitro.
J. Stork et al. / Virology 343 (2005) 79–9284
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p33:RNA complexes in vitro
To test if phosphorylation of p33 could promote the
release of the RNA from the p33:RNA complex, we treated
the prebound p33:RNA complex with PKC (Fig. 4C). This
experiment demonstrated that phosphorylation of p33 could
promote the release of viral RNA from the complex. The
release of RNA from the RNA:p33 complex is due to
phosphorylation of S210 and T211 because RNA release after
PKC treatment was not observed with the nonphosphory-
latable A210A211 p33 mutant (Fig. 4C). In addition, we
demonstrated that p33 bound to the viral RNA can be
phosphorylated in vitro with PKC (Fig. 4D). Therefore, the
obtained data are consistent with a model that phosphory-
lation can stimulate the release of the viral RNA from p33
and/or p33-containing replicase complexes.
Phosphorylation-mimicking p33 mutant inhibits the in vitro
activity of functional CNV replicase complex
To test if phosphorylation of p33 affects the activity and/
or the assembly of functional replicases in yeast host, we co-
expressed one of the p33 phosphorylation-mimicking
mutants with wt p92 and DI-72 RNA as described (Panavas
and Nagy, 2003b; Panaviene et al., 2004). To this end, we
prepared two types of replicase preparations 40 h after
induction of DI-72 RNA transcription from the pYES-DI-72
expression plasmid. One of the preparations was the
membrane-enriched fraction, which contained functional
preassembled CNV replicase complexes that could synthe-
size new RNA strands using the co-purified (endogenous)
DI-72 RNA template (Fig. 5A) (Panavas and Nagy, 2003b;
Panaviene et al., 2004). The second preparation was
obtained by affinity purification of CNV replicase, which
is able to use added (exogenous) RNA templates for
complementary RNA synthesis (Fig. 5B) (Panaviene et al.,
2004). In comparison with the control experiments includ-
ing wt p33 and wt p92, which resulted in highly active CNV
replicase preparations, the membrane-enriched and the
affinity-purified D210D211 p33-containing CNV replicasesFig. 4. Phosphorylation inhibits the ability of p33 to bind to the viral RNA and facil
performed with purified recombinant p33 (wt or A210A211) treated prior to RNA bi
(marked as ‘‘PKC-ATP’’). The probe was the 32P-labeled RII(+)-SL RNA as describ
at the bottom. The free RNA probe in the absence of p33 is taken as 100%.
phosphorylated with PKC (lanes 2–5) in the presence of 32P g-ATP and DC99 (la
contains only the DC99 RNA probe as a marker. Left panel: the gel was stained with
differ by 1 nt in length). Note the presence of a unique band in lanes 4–5, which r
RNA probe cannot bind to p33 (Pogany et al., 2005), thus there is no detectable p33
was stained with Coomassie blue to visualize p33. Note that the p33:RNA complex
same position in the gel when compared with the left panel. Right panel: detection o
and middle panels. Note the lack of 32P-labeled p33 (i.e., the phosphorylated form o
these results suggest that the unphosphorylated form of p33, which is apparently sti
shift visualized in the left and middle panels. (C) EMSAwas performed with wt 32P
A, except that the PKC treatment was done after the RNA binding reaction (i.e., af
RNA is shown below the gel. The free RNA probe in the absence of p33 is taken as
presence of RII(+)-SL RNA template (0, 1 or 2 Ag, as shown). Note that PKC can pwere not functional without or with added RNA templates
(Figs. 5A–B). The amounts of p33 present in these CNV
replicase preparations were comparable to those in the wt
p33-containing preparations (Figs. 5A–B). Thus, the
stability and/or expression level of p33 is not affected by
the D210D211 mutations in yeast. The simplest explanation
of these observations is that the phosphorylation-mimicking
D210D211 p33 inhibited the activity and/or the assembly of
functional replicase complexes in yeast.
In vitro testing of the CNV replicase activity in
preparations containing the nonphosphorylation-mimicking
A210A211 and A205A210A211 p33 revealed reduced levels of
RNA synthesis (between 29 and 45%) in both endogenous
and exogenous template-containing reactions (Figs. 5A–B).
This suggests that the nonphosphorylated p33 could
participate in CNV replicase assembly. However, the
assembly and/or activity of the CNV replicase containing
nonphosphorylation-mimicking p33 is somewhat less effi-
cient than those containing wt p33 (see Discussion).
Additional tests revealed that the hypophosphorylation-
mimicking D211 p33 supported the activity of CNV replicase
by five-fold less efficiently than the wt p33 did (Figs. 5A–
B). The amounts of p33 present in these CNV replicase
preparations were comparable (Figs. 5A–B).
To test if similar phosphorylation-mimicking mutation
(i.e., D210D211) could affect the activity of p92 RdRp
protein, we co-expressed the mutated p92 with wt p33 in
yeast followed by obtaining CNV replicase preparations.
These tests revealed that phosphorylation-mimicking muta-
tion in p92 did not inhibit the activity of the membrane-
bound CNV replicase (Fig. 5A). This suggests that
phosphorylation of p92 at positions S210 and T211 is unlikely
to affect its polymerase activity in vivo.
CNV replicase containing nonphosphorylation-mimicking
p33 shows reduced ratio in plus- versus minus-strand
synthesis
Reduction of template activity by CNV replicase pre-
parations containing nonphosphorylation-mimicking p33
(Fig. 5) suggests that phosphorylation of T205, S210 anditates the release of bound RNA from the p33:RNA complex. (A) EMSAwas
nding with PKC in the presence (marked as PKC + ATP) or absence of ATP
ed in the legend to Fig. 2. The percentage of free RNA is shown graphically
(B) EMSA was performed as described in panel A, except that p33 was
nes 1–3) or wt RII(+)-SL (lanes 4–5) RNA probes were unlabeled. Lane 1
ethidium bromide to visualize the RNA probes (DC99 and wt RII(+)-SL only
epresents the p33:RNA complex (depicted by a double headed arrow). DC99
:RNA complex in lanes 2–3. Middle panel: the same gel as in the left pane
(depicted by a double headed arrow) was detected only in lanes 4–5 at the
f 32P-labeled p33 with a PhosphorImager from the same gel shown in the lef
f p33) in the area of p33:RNA complex (depicted by an asterisk). Therefore
ll present after PKC treatment, is responsible for the observed RNA mobility
-labeled RII(+)-SL and unlabeled p33 (wt or A210A211) as described in pane
ter the formation of the stable p33:RNA complex). The percentage of bound
100%. (D) Phosphorylation of purified p33 with PKC using 32P g-ATP in the
hosphorylate p33 even in the presence of excess amounts of RNA templatesl
t
,
l
.
Fig. 5. Phosphorylation-mimicking mutations in p33 inhibit the assembly of functional CNV replicase complexes in yeast. (A) In vitro activity of CNV
replicase present in membrane-enriched preparations. Each replicase preparation, obtained from yeast co-expressing p33, p92 and DI-72(+) RNA, was tested
with the co-purified endogenous template (no template was added). 32P-labeled RNA products from the above preparations were analyzed on denaturing 5%
PAGE/8 M urea gels. For quantification, we measured the intensity of 32P-labeled RNA products by using a PhosphorImager. Activity of the CNV replicase
obtained from yeast expressing the wt p33 [in addition to wt p92 and DI-72(+) RNA] corresponds to 100%. Each experiment was performed three times.
Western blot (at the bottom) shows the p33 levels in the membrane-enriched preparations. Similar replicase assay with membrane-enriched preparations
containing mutated p92 and wt p33 is shown on the right. Note that phosphorylation-mimicking mutations in 92 (D210D211), unlike in p33, did not reduce CNV
replicase activity. (B) In vitro activity of affinity purified CNV replicase preparations. Each replicase preparation, obtained from yeast co-expressing p33, p92
and DI-72(+) RNA, was tested in the presence of exogenous RI/III() template, which contains the minus-stranded regions I and III of DI-72 in a standard
CNV replicase assay. Analysis of the replicase products and quantification were done as described in panel A. Western blot (at the bottom) shows the p33 levels
in the affinity-purified CNV replicase preparations.
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replicase assembly and/or viral RNA synthesis. To test the
effect of phosphorylation of p33 on RNA synthesis by the
CNV replicase, first, we treated the CNV replicase with
PKC prior to the replicase assay. As shown in Figs. 6A–B,
PKC treatment had no significant effect on template activity
of the CNV replicase bound to its template (endogenous
RNA, Fig. 6A) or on the purified CNV replicase with added
template (Fig. 6B). These data suggest that the preas-
sembled CNV replicase:RNA complex (with the RNA likely
bound to the p92 RdRp protein in the replicase complex) is
not sensitive to phosphorylation in vitro.
In the second assay, we tested the ratio of in vitro
synthesized (+) and () strands by the wt and mutated CNV
replicases co-purified with their template RNAs (Fig. 7).Fig. 6. Phosphorylation does not inhibit the activity of the preassembled
functional CNV replicase complexes in vitro. (A) Enriched membrane
fractions with endogenous templates, or (B) affinity-purified CNV replicase
preparations programmed with RI/III() template, were treated with PKC
prior to the replicase assay. See further details in the legend to Fig. 5.Briefly, in this assay, the ‘‘membrane-enriched’’ replicase
fraction containing the endogenous viral RNA synthesizes
complementary RNA in vitro in the presence of 32P-UTP
and the three other ribonucleotides (‘‘replicase run off’’
experiments). The resulting new 32P-labeled RNA strands
are then used as probes in RNA blot experiments that have
the same amounts of denatured plus- and minus-strand RNA
blotted on the membrane (Panaviene et al., 2004). Based on
measuring hybridization to (+) and () strands of viral
RNA, we can estimate the ratio of plus- and minus-strand
templates present originally in the membrane-enriched
fractions. The replicase run off experiments revealed that
at the early time point (12 h) the CNV replicase containing
nonphosphorylation-mimicking p33 mutant (A205A210A211)
synthesized over 10 times more minus strands than plus
strands (Fig. 7). On the contrary, the wt replicase syn-
thesized almost the same amounts of minus- and plus
strands. At 18 h time point, the wt replicase produced ¨6
times more plus strands than minus strands, whereas the
CNV replicase containing either A210A211 or A205A210A211
p33 synthesized only ¨3 and ¨1.5 more plus strands
than minus strands. Interestingly, the difference in plus- and
minus-strand ratio between the wt and A205A210A211 mutant
replicase was still ¨7-fold at 24 h time point, suggesting
that replicase with the nonphosphorylation-mimicking p33
has lower preference for plus-strand synthesis (i.e., less
asymmetrical RNA synthesis) than the wt replicase.
The CNV replicase containing hypophosphorylation-
mimicking p33 (i.e., D210A211) lacked detectable level of
template activity at the early time points, whereas it
Fig. 7. Effect of phosphorylation site mutations in p33 on in vitro asymmetrical RNA synthesis by the CNV replicase obtained from yeast. Top: the RNA blots
show the (+) and () strand synthesis by the in vitro CNV replicase. Unlabeled T7 RNA polymerase transcripts of DI-72(+) and DI-72() (400 ng each),
marked as + and =, respectively, were blotted on the membrane. The blotted RNAs were then hybridized with denatured 32P-labeled RNA probes, which were
generated by the CNV replicase in vitro on the endogenous templates present in the enriched membrane fractions obtained from yeast. Time points for
harvesting the yeast samples for isolation of enriched membrane fractions are shown on the top. Bottom: the ratio between plus- and minus-stranded RNAs in
the in vitro replicase assay was calculated based on PhosphorImager analysis from three separate experiments.
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the 30 h time point (Fig. 7). This suggests that the assembly
of CNV replicase is inefficient in yeast expressing D210A211
p33, which could be due to inefficient RNA binding (Fig.
2), thus inefficient template recruitment into replication.Discussion
In this work, we characterized the effects of phosphory-
lation of conserved S/T residues located adjacent to an
essential RNA binding domain on the properties of tombus-virus p33 replication protein. Specifically, we found that the
phosphorylated form of p33 showed reduced RNA binding in
vitro (Figs. 4A–B). Moreover, phosphorylation of the
p33:viral RNA complex with PKC in vitro promoted the
release of the viral RNA from the complex (Fig. 4C). This
was further supported by the reduced RNA binding capacity
of recombinant phosphorylation-mimicking D for S/T
mutants of p33 (Fig. 2). Altogether, these data are consistent
with the model (see Fig. 1) that the negative charges
introduced at T205, S210 and T211 adjacent to the RNA
binding domain by phosphorylation can inhibit the binding of
the negatively charged viral RNA to the positively charged
J. Stork et al. / Virology 343 (2005) 79–9288RPRmotif in p33. Based on these characteristics, phosphory-
lation/dephosphorylation of p33 adjacent to the RNA binding
site is likely involved in regulation of p33:viral RNA
interaction, and it could serve as an on/off switch in viral
RNA binding/RNA release (see below).
In vitro testing of CNV replicase complexes obtained
from yeast cells revealed that the purified CNV replicase
containing phosphorylation-mimicking p33 (i.e., D210D211)
lacked replicase activity on an added template (Fig. 5B).
Moreover, the replicase preparation containing D210D211
p33 was also inactive on the co-purified RNA template (Fig.
5A). The lack of CNV replicase activity could be due to
deficiency of phosphorylation-mimicking D210D211 p33 in:
(i) binding/holding to the template during the in vitro
reaction (Fig. 2); and/or (ii) supporting replicase assembly
in vivo prior to replicase purification (Fig. 6A). This is
because the viral RNA template is known to stimulate the
assembly of functional replicase complexes by 40- to 100-
fold in tombusviruses (Panaviene et al., 2004, 2005). On the
other hand, it is unlikely that translation and/or stability of
p33 were altered by these mutations because yeast cells
expressed the phosphorylation-mimicking D210D211 p33 in
comparable amount to wt p33 (Fig. 4). On the contrary, the
RdRp function of D210D211 p92 was not altered by these
modifications, suggesting that phosphorylation of S/T
residues adjacent to the RPR motif is expected to have
different effect on p92 functions than on p33 functions.
Based on the above and previous observations (Pan-
aviene et al., 2004; Shapka et al., 2005, accompanying
paper), we propose that the CNV replicase complex in yeast
expressing phosphorylation-mimicking D210D211 p33 lacks
template activity likely because it (i) contains reduced
amount of viral RNA due to decreased capacity of the
mutated p33 in RNA binding, which in turn (ii) leads to
deficiency in template recruitment (Pogany et al., 2005) and
(iii) inefficient replicase assembly due to limited amount of
‘‘RNA assembly platform’’ for p33, p92 and putative host
proteins (Panaviene et al., 2004). Altogether, inefficient
replicase assembly in combination with poor template
binding and increased RNA release from the replicase
complex could explain the lack of detectable CNV replicase
activity in membrane-enriched and purified replicase prep-
arations obtained from yeast expressing D210D211 p33 (Figs.
5A–B). Altogether, we propose that phosphorylation of
T205, S210 and T211 amino acid residues in p33 by a host
kinase could lead to ‘‘shut down’’ of new replicase assembly
and recruitment of viral RNA into replication during the late
phase of the replication cycle. This could help in switching
the role of the viral RNA from replication to other
processes, such as viral RNA encapsidation and possibly
cell-to-cell movement in infected hosts. In addition, early
hyperphosphorylation of p33 in selected host plants could
lead to resistance against tombusviruses by interference with
replicase assembly and template binding.
Interestingly, the activity of preassembled replicase
complex was not affected by kinase treatment in vitro (Fig.6), suggesting that phosphorylation of p92 RNA-dependent
RNA polymerase within the replicase complex does not alter
its ability to bind to the RNA template. This could be due to
the presence of two extra RNA binding regions in p92 in
addition to the RPR motif (Rajendran and Nagy, 2003), thus
allowing the replicase to perform RNA synthesis on
templates that are present within preassembled replication
complexes.
The wt nonphosphorylated recombinant p33 and the
nonphosphorylation-mimicking A for S/T mutants of p33
bound to viral RNA stably in vitro (Fig. 2), and they also
supported the assembly of functional CNV replicase com-
plexes in yeast (Fig. 5). These observations are consistent
with the model that the nonphosphorylated form of p33 is
replication-competent, whereas the fully phosphorylated
form is replication incompetent. However, both nonphos-
phorylated and phosphorylated forms likely play some, albeit
different, roles in tombusvirus replication. This is supported
by the observation that the CNV replicase containing the
phosphorylation incompetent p33 (i.e., A210A211 and
A205A210A211) showed 3- to 7-fold reduction in plus- versus
minus-strand synthesis when compared to the CNV replicase
containing the wt p33 (Fig. 7). In other words, the CNV
replicase containing the nonphosphorylation-mimicking p33
produced less plus-stranded RNA and/or relatively more
minus-stranded RNA than the replicase with the wt p33. This
could be due to the reduced release rates of viral RNA
templates by the phosphorylation incompetent p33 from the
replication sites or altered functionality of the CNV replicase
containing A205A210A211 p33. Altogether, we propose that
phosphorylation plays a role in fine-tuning of the asym-
metrical replication process (see below).
The role of phosphorylation of S/T residues adjacent to the
RNA binding site in p33 in the replication process could be
more complex, however, due to the possible presence of
partially (hypo-)phosphorylated p33 forms (see accompany-
ing paper, Shapka et al., 2005), which might have different
functions than the fully phosphorylated form of p33 in
infected cells. Accordingly, hypophosphorylation-mimick-
ing p33 mutants (i.e., D210A211, A210D211) showed reduced
viral RNA binding in vitro (Fig. 2) when compared to the
nonphosphorylated wt p33. In addition, CNV replicase
preparations containing D210 p33 showed reduced template
activity and produced small amount of plus-stranded RNA
when compared to the replicase preparations with the wt p33
(Figs. 5A–B). Overall, hypophosphorylation of p33 could
play a role in regulation of subgenomic RNA synthesis (see
accompanying paper, Shapka et al., 2005) and fine-tuning of
the asymmetrical replication process.
A model on the role of phosphorylation of p33 in regulation
of tombusvirus replication
The p33 replication protein plays a role in selection of the
viral RNA via selectively binding to a conserved stem-loop
region in the p92 ORF [RII(+)-SL representing p33RE]
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2005). This selective template binding by p33 is important
for recruitment of the viral RNA from translation into
replication, which takes place in membranous structures
derived from peroxisomes (Navarro et al., 2004; Panavas et
al., 2005). Moreover, the p33:RNA complex is essential for
the assembly of the viral replicase complex (Panaviene et al.,
2004), which also contains p92 and possibly host factors.
Based on data presented in this and the accompanying paper
(Shapka et al., 2005, accompanying paper), we propose that
the template selection and replicase assembly functions are
performed by the nonphosphorylated form of p33, and these
processes are inhibited by the phosphorylated form of p33.
After the assembly of the replicase complex, hypophospho-
rylation of p33 (probably at S210 and T211 positions) could
facilitate minus-strand and/or subgenomic RNA synthesis.
Phosphorylation of p33 at T211 position (or combined
phosphorylation of T205, S210 and T211 sites), however, is
predicted to decrease the RNA binding capacity of p33
drastically, which could facilitate the release of newly
synthesized RNA (both genomic and subgenomic) from
the replication units/sites (Fig. 8). Because phosphorylation
and dephosphorylation of p33 might take place repeatedly in
cycles, one replication unit could potentially produce and
release tombusviral RNA progenies multiple times. Overall,
phosphorylation of p33 could help in regulating (fine-tuning)
the replication and infection processes.
Cellular processes other than p33 phosphorylation (such
as protein modification, protein degradation, diffusion or
membrane rearrangements) could also promote the release of
viral RNA from the replication units/sites, likely explaining
why the nonphosphorylatable p33 (either A210A211 or
A205A210A211) still could support virus replication (Shapka
et al., 2005, accompanying paper). However, theFig. 8. A model on the role of phosphorylation of p33 in CNV replication. (A) At
actively involved in the assembly of the CNV replicase, and the recruitment of t
peroxisomes. The single vesicle schematically shows a hypothetical replication un
and the (+)-stranded viral RNA (purple). Hypophosphorylation of p33 might affec
Phosphorylation of p33 leads to decreased RNA binding, thus facilitating the rele
replication. The released viral RNA will likely participate in new rounds of trans
point, the phosphorylated p33 cannot participate in the assembly of new CNV repl
‘‘X’’). A possible role of phosphorylation in the disassembly/degradation of replinonphosphorylatable p33 mutants are slower in replication
in single cells, and they are less potent in invading the host
plants as rapidly as the wt virus can (Shapka et al., 2005,
accompanying paper). Altogether, these deficiencies of the
nonphosphorylatable p33 in supporting tombusvirus repli-
cation could be especially detrimental in competitive
environment where tombusviruses with phosphorylatable
p33 are also present.
One of the proposed roles of p33 phosphorylation
adjacent to the RNA binding site in fine-tuning the
replication process is to regulate/stimulate the release of
viral RNA from the replication sites. This might be
important because the nonphosphorylated p33 binds the
viral RNA rather tightly, which is advantageous for template
selection during early steps of replication. On the contrary,
at latter steps of replication, tight binding between p33 and
the viral RNA could slow down the release of the newly
made viral RNAs from the replication sites. This could be
disadvantageous because the viral RNA has to participate in
other processes, such as translation (i.e., sgRNAs), assembly
of new replicase complexes, cell-to-cell movement and
encapsidation. Altogether, the current work promotes a
novel, fine-tuning role for p33 phosphorylation adjacent to
the RNA binding site in tombusvirus replication.Materials and methods
Expression and purification of recombinant replicase
proteins from E. coli
Expression and purification of the recombinant CNV p33
replicase protein (termed p33C, lacking the hydrophobic N-
terminal domain) were carried out as described earlierthe beginning of infection, the freshly translated nonphosphorylated p33 is
he viral RNA template to membranous vesicles formed on the surfaces of
it, based on BMV (Schwartz et al., 2002), with numerous p33, several p92
t the ratio of plus- versus minus-strand synthesis by the CNV replicase. (B)
ase of the newly synthesized genomic and subgenomic RNA progeny from
lation, cell-to-cell movement and/or encapsidation. However, at later time
icase complexes, thus resulting in shut down of replication (indicated by an
case complexes is also shown.
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the expression plasmids carrying wt or mutated p33C
sequences were transformed into E. coli [Epicurion BL21-
CodonPlus (DE3)-RIL (Stratagene)]. Protein expression was
induced at 14 -C with 0.3 mM IPTG (isopropylthiogalacto-
pyranoside) for 8 h. The recombinant proteins were purified
using amylose resin column (NEB), as described earlier
(Rajendran and Nagy, 2003; Rajendran et al., 2002). All
protein purification steps were carried out in a cold room.
The purified recombinant proteins were analyzed in a 10%
SDS-PAGE for their purity. The Bio-Rad protein assay was
used to measure the amount of purified recombinant
proteins.
Gel mobility shift assay (EMSA)
RNA templates were obtained using T7 RNA polymerase-
based transcription on PCR templates in the presence of
32P-labeled UTP and unlabeled ATP, CTP and GTP as
described (Pogany et al., 2003, 2005). After phenol/
chloroform extraction and isopropanol/ammonium acetate
precipitation, the obtained RNA probes were checked by
5% PAGE/8 M urea electrophoresis.
The affinity purified recombinant proteins (1 Ag or as
mentioned in the figure legends) were incubated with 1 ng
of radioactively labeled RNA probe (see above) in a
binding buffer [50 mM Tris–HCl pH 8.2, 10 mM MgCl2,
10 mM DTT, 10% glycerol, 200 ng yeast tRNA (Sigma)
and 2 U of RNase inhibitor (Ambion)] at 25 -C for 15 min
(Rajendran and Nagy, 2003). After the binding reaction,
the samples were analyzed by 5% non-denaturing poly-
acrylamide gel electrophoresis in TAE buffer performed at
200V in a cold room (Rajendran and Nagy, 2003). The
gels were dried and analyzed in a PhosphorImager and
quantified using ImageQuant v.1.2 (Amersham). To study
the effect of phosphorylation on the RNA release from
p33, we treated the prebound RNA:p33 complex (see the
binding assay above) with PKC (Sigma) as described in
the accompanying paper (Shapka et al., 2005) prior to
electrophoresis.
Yeast transformation and growth
S. cerevisiae strain INVSc1 (Invitrogen) carrying three
plasmids [i.e., pGAD-His92, pGBK-His33 and pYC-DI-
72(+)Rz, (Panaviene et al., 2004)] was grown in SC-ULT
medium containing 2% galactose for 24 h at 30 -C (Panavas
and Nagy, 2003a). Then, the cultures were diluted 10-fold
with fresh SC-ULT medium with 2% galactose and grown at
23 -C until 0.6–0.7 OD600 (approximately 24 h). Yeast cells
were then harvested by centrifugation at 2000  g for 5 min
followed by washing the pellet with 20 mM Tris–HCl, pH
8.0 and centrifugation. The pelleted cells were re-suspended
in 1 ml of 20 mM Tris–HCl, pH 8.0 buffer, followed by
centrifugation at 21,000  g for 1 min and storage of the
pellet at 80 -C until further use.CNV replicase assays
First, we obtained ‘‘membrane-enriched’’ CNV replicase
preparations, which are suitable to test the replicase activity
on the endogenous templates present within the CNV
replicase preparation (Panaviene et al., 2004). Frozen yeast
cells were homogenized by grinding in liquid nitrogen
followed by addition of the extraction buffer (200 mM
sorbitol, 50 mM Tris–HCl, pH 7.5, 15 mM MgCl2, 10 mM
KCl, 10 mM g-mercaptoethanol, yeast protease inhibitor
mix, Sigma) and centrifugation at 100 g for 1.5 min at 4 -C
(Panavas and Nagy, 2003a). Because no template was added
to the in vitro reaction, the replicase preparation could only
use the endogenous template present within the enriched
membrane fraction. The RdRp products were phenol/chloro-
form-extracted, precipitated with isopropanol/ammonium
acetate and analyzed under denaturing conditions (i.e., 5%
PAGE containing 8 M urea (Pogany et al., 2003).
The second preparation was affinity-purified CNV
replicase, which can accept exogenous templates. The
CNV replicase was purified via metal-affinity purification
as described (Panaviene et al., 2004). Briefly, the above
enriched membrane fraction was solubilized in 1% Triton
X-100 and 5% SB3-10 (caprylyl sulfobetaine) (Sigma)
followed by binding to ProBond resin (Invitrogen). After
careful washing, the recombinant p33 was recovered from
the column in the extraction buffer containing 200 mM
imidazole and 0.1% Triton X-100. We used 0.5 Ag RNA
templates [RI/RIII()] and 25 Al of recombinant CNV
replicase (Panaviene et al., 2004). The RdRp products were
phenol/chloroform-extracted and analyzed under denaturing
conditions (see above).
Plus- and minus-strand assay
To test the ratio of (+) versus () strand synthesis on the
endogenous templates by the CNV replicase, we obtained the
membrane-enriched fraction (see above) followed by stand-
ard replicase assay in the presence 32P-labeled UTP and the
other three unlabeled rNTPs followed by phenol/chloroform
extraction and isopropanol precipitation. The obtained RNA
probe and equal amounts of in vitro transcripts of DI-72(+)
and () RNAs, prepared by T7 RNA transcription (see
above), were denatured separately by heating for 5 min at
85 -C in TE buffer and formamide (in 1:1 ratio). Then, the
DI-72(+) and ()RNAs were separately blotted onto a
Hybond XL membrane (Amersham) and crosslinked with
UV (GS Gene Linker, Bio-Rad). Hybridization was done
using ULTRAhyb solution (Ambion) at 68 -C according to
the supplier’s instructions. The 32P-labeled replicase pro-
ducts were used as probes for hybridization.
Western blot
Aliquots (10 Al) of the enriched membrane fraction from
yeast cells or the purified p33 preparations in SDS-PAGE
J. Stork et al. / Virology 343 (2005) 79–92 91sample loading buffer (Sambrook et al., 1989) were heated
for 5 min at 85 -C, electrophoresed in 10% SDS-PAGE gels
and electrotransferred to a PVDF membrane (Bio-Rad).
Then, CNV His-p33 was detected with monoclonal anti-His
antibodies (Amersham) and secondary alkaline phospha-
tase-conjugated anti-mouse antibody (Sigma) as described
(Pogany et al., 2005). Western blots were developed using
BCIP and NBT (Sigma).Acknowledgments
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